Overview

Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses

Status:
Recruiting
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
The central goal of this application is to demonstrate the causal contribution of reward learning signals (expected values and reward prediction errors [RPE]) to antidepressant responses (Aim1) by experimentally manipulating expected values using transcranial magnetic stimulation (TMS) targeting the vmPFC (Aim 2) and μ-opioid striatal RPE signal using pharmacological approaches (Aim 3).
Phase:
Phase 4
Details
Lead Sponsor:
Marta Peciña MD PhD
Marta Peciña, MD PhD
Treatments:
Analgesics, Opioid
Buprenorphine
Naltrexone
Narcotic Antagonists